Roche

Samsung Biologics doubling capacity through third Korean plant

photo - Nelosa/iStock

Samsung Biologics has invested $740m to build a third facility in Korea, adding a further 180,000L of mammalian cell culture capacity.

Catalent: Suspension at French softgel plant likely due to tampering

Catalent: Suspension at French plant likely due to human interference

Roche: Small molecule exit will lead to outsourcing opportunities

Roche: Small molecule exit will lead to outsourcing opportunities

People on the Move

The week in outsourcing appointments

Genentech's Vacaville, CA plant is one of Roche's manufacturing sites being expanded

Roche expanding capacity 40% across network, but will still use CMOs

DSM-Sinochem plant in Toansa India

Environmental group welcomes DSM-Sinochem and GSK efforts to halt spread of antibiotic resistance

FDA offers guidance for running early-phase trials for gene, cell therapies

FDA offers guidance for running early-phase trials for gene, cell therapies

On the move: arrivals and departures at Parexel, Novartis, Roche

On the move: arrivals and departures at Parexel, Novartis, Roche

Antiquated clinical trial industry ripe for change from innovation, experts say

Antiquated clinical trial industry ripe for change from innovation, experts say

What's in a name? Genentech's discovery means cell lines can be identified more easily.

Genentech makes cell line identification faster and cheaper

More Roche